Superworth

Glucotrack revenue GCTK

Sales by quarter and over the last twelve months, from 2014.

Last 12 months, to Sep 30, 2020
$70K
Latest quarter, Q3 FY20
$0
−100% on a year earlier
Fiscal year 2019
$208K
+378% on the year before

Glucotrack's revenue was $70K over the twelve months to Sep 30, 2020, down 50% on a year earlier.

In its latest quarter, Q3 FY20, it was $0, down 100% on the same quarter a year before.

Revenue over time

Open the interactive chart, with overlays and comparisons

Fiscal year by fiscal year

Fiscal yearRevenueChange
FY2019$208K+378%
FY2018$43.5K−93%
FY2017$589.5K+312%
FY2015$143.2Kn/a
FY2014n/an/a

Each fiscal year is the twelve months to its fourth quarter.

Quarter by quarter

QuarterEndedRevenueOn a year earlierLast 12 months
Q3 FY20$0−100%$70K
Q2 FY20$97−100%$74.2K
Q1 FY20$2.2K−91%$184.6K
Q4 FY19$67.7Kn/a$208K
Q3 FY19$4.2Kn/a$140.3K
Q2 FY19$110.5K+623%$136.1K
Q1 FY19$25.6K−9%$40.8K
Q4 FY18$0−100%$43.5K
Q3 FY18$0−100%$507.1K
Q2 FY18$15.3K+75%$528K
Q1 FY18$28.2K−71%$521.4K
Q4 FY17$463.6Kn/a$589.5K

Against its peers

Companies in Medical - Instruments & Supplies nearest Glucotrack's size, closest first, today.

CompanyRevenue, 12 monthsGrowth
GCTKGlucotrackn/m
PFSAProfusan/m
VJETFlyte Aviation$1.9M+219% a year
BBLGBone Biologicsn/m
IVFINVO Fertility$7.5M+14% a year
TNONTenon Medical$5.3M+80% a year
XAIRBeyond Air$7.7M+61% a year
ADGMAdagio Medical$0
AMIXAutonomix Medicaln/m
NXGLNexgeln/m
BJDXBluejay Diagnosticsn/m
Peer median$5.3M

What the revenue tells you

Total sales in the period. On the company page, quarterly bars or the trailing twelve months (TTM), which smooths seasonality.

Growing revenue with shrinking margins is a warning, not a win.

More on Glucotrack

Valuation data, not investment advice. Prices as of . Reported figures come from the company's filings with the SEC.